Prevention of nephropathy in patients with type 2 diabetes mellitus

被引:12
|
作者
Tzamaloukas, Antonios H.
Murata, Glen H.
机构
[1] New Mexico Vet Affairs Hlth Care Syst, Nephrol Sect, Albuquerque, NM 87108 USA
[2] New Mexico Vet Affairs Hlth Care Syst, Gen Internal Med Sect, Albuquerque, NM 87108 USA
[3] Univ New Mexico, Sch Med, Dept Med, Albuquerque, NM 87131 USA
关键词
diabetic nephropathy prevention; glycemia; hypertension; lipid metabolism; nephrotoxins; type; 2; diabetes;
D O I
10.1007/s11255-005-2394-3
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
The rising incidence of type 2 diabetes mellitus and of its complications will make it the most important health care challenge in the first quarter of the 21st Century. Diabetic nephropathy left unchecked will overwhelm the renal resources. Simple methods ( proper diet and exercise, prevention of obesity) are successful in preventing type 2 diabetes in the great majority of the persons at risk. In patients with established type 2 diabetes, nephropathy can be prevented or greatly delayed by strict metabolic control, strict control of blood pressure using angiotensin-converting enzyme inhibitors and angiotensin receptor blockers as the first line of drugs, tight control of serum lipids using statins as indicated, low protein diet, avoidance of smoking and other nephrotoxic influences, prevention of abnormalities in calcium/phosphorus metabolism, and prevention of renal anemia by the early use of erythropoietin. Current research offers the promise of definitive prevention of both type 2 diabetes and diabetic nephropathy.
引用
收藏
页码:655 / 663
页数:9
相关论文
共 50 条
  • [1] Prevention of Nephropathy in Patients with type 2 Diabetes Mellitus
    Antonios H. Tzamaloukas
    Glen H. Murata
    [J]. International Urology and Nephrology, 2005, 37 : 655 - 663
  • [2] Nephropathy in patients with type 2 diabetes mellitus
    Ritz, E
    Orth, SR
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (15): : 1127 - 1133
  • [3] The Characteristic of Korean type 2 diabetes mellitus patients with nephropathy
    Lee, Yoon Jung
    Yeo, Eun-Sil
    Hwang, Ji-Yun
    Park, Jong Suk
    Choi, Young Ju
    Huh, Kap Bum
    Kim, Wha Young
    [J]. FASEB JOURNAL, 2009, 23
  • [4] Prevalence of nephropathy in black patients with type 2 diabetes mellitus
    Gitter, J
    Langefeld, CD
    Rich, SS
    Pedley, CF
    Bowden, DW
    Freedman, BI
    [J]. AMERICAN JOURNAL OF NEPHROLOGY, 2002, 22 (01) : 35 - 41
  • [5] Nephropathy of type-2 diabetes mellitus
    Ruggenenti, P
    Remuzzi, G
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1998, 9 (11): : 2157 - 2169
  • [6] Detection of early nephropathy in Mexican patients with type 2 diabetes mellitus
    Cueto-Manzano, AM
    Cortes-Sanabria, L
    Martinez-Ramirez, HR
    Rojas-Campos, E
    Barragan, G
    Alfaro, G
    Flores, J
    Anaya, M
    Canales-Munoz, JL
    [J]. KIDNEY INTERNATIONAL, 2005, 68 : S40 - S45
  • [7] Evaluation of Early Markers of Nephropathy in Patients with Type 2 Diabetes Mellitus
    De Muro, Pierina
    Lepedda, Antonio Junior
    Nieddu, Gabriele
    Idini, Michela
    Nguyen, Hai Quy Tram
    Lobina, Omar
    Fresu, Pietro
    Formato, Marilena
    [J]. BIOCHEMISTRY RESEARCH INTERNATIONAL, 2016, 2016
  • [8] Intensified treatment of patients with type 2 diabetes mellitus and overt nephropathy
    Joss, N
    Ferguson, C
    Brown, C
    Deighan, CJ
    Paterson, KR
    Boulton-Jones, JM
    [J]. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2004, 97 (04) : 219 - 227
  • [9] Lipid Abnormalities in Type 2 Diabetes Mellitus Patients with Overt Nephropathy
    Palazhy, Sabitha
    Viswanathan, Vijay
    [J]. DIABETES & METABOLISM JOURNAL, 2017, 41 (02) : 128 - 134
  • [10] Progression of diabetic nephropathy in Saudi patients with type 2 diabetes mellitus
    Al Suleiman, Mohamed H.
    Kfoury, Hala K.
    Jondeby, Mohamed S.
    Burgos, Noel S.
    Al Hayyan, Hajjar
    Al Sayyari, Abdulla
    [J]. ENDOCRINOLOGIST, 2008, 18 (05): : 230 - 232